Careers

Why Cogent

At Cogent, we thrive on collaboration, creativity, and pushing the boundaries of innovation. As a fast-moving, late-stage clinical development company with a rapidly evolving pipeline, we value ingenuity and welcome fresh ideas. In our dynamic and supportive environment, your contributions directly impact the future of our programs and drive our success. Every voice matters and together we shape the path forward through bold, forward-thinking solutions.

Our Corporate Values
Our Team
At Cogent, our focus is to use all available knowledge, skills and tools to rapidly create new medicines to help patients with genetically-driven diseases.
John Robinson, PhD
Chief Scientific Officer
Cheryl Napier
Senior Research Project Manager

What fuels my passion to work at Cogent are the patients. The 33-year-old woman with untreatable ovarian cancer. The man 2 months older than me with metastatic melanoma. The 76-year-old woman with lymphoma, who, thanks to treatment-induced remission, was able to hold her first grandchild.

The biggest appeal about the culture at Cogent was the promise of a transparent, fast-moving, and collaborative work environment.
LouAnn Cable
Senior Principal Scientist, Cell Biology
What We Offer
Our Open Roles
We are passionate, driven, collaborative, curious, and hard-working. If you thrive in a fast-paced environment and are excited by the opportunity to contribute to meaningful science and meaningful therapies for patients, join us!

This link leads to the machine readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.

Scroll to Top
All Categories
Cole Pinnow

Chief Commercial Officer

Cole is an accomplished executive with extensive commercial development, new product launch, P&L, and strategic leadership experience over a 20 plus year career in the pharmaceutical industry, with a specific focus on oncology. Before joining Cogent as Chief Commercial Officer, he served at Pfizer as the Global Franchise Lead for its Genitourinary, Lung and Breast Oncology Businesses. In this role, he oversaw the global launch and lifecycle strategy for Xtandi® + Talzenna® in mCRPC. Before that, he was President of Pfizer Canada where he was accountable for the company’s operations within the country, including sales, marketing, access and government relations. He was also VP of a US commercial business unit which had tremendous growth under his leadership. Prior to working at Pfizer, Cole held management positions at both Hospira, Inc., a global pharmaceutical and medical device company, in global pharmaceuticals, global marketing and commercial development. He holds an MBA from the University of Chicago Booth School of Business, a Master of Science degree in Microbiology from Iowa State University, and a Bachelor’s Degree in Biology from St. Olaf College. In his spare time, Cole enjoys swimming, hiking and skiing.